While clinical trials show adults on the highest dose of Zepbound lose an average of 22.5% of their body weight after 72 weeks (when paired with diet and exercise), recent Phase 3 trial data (from the TRIUMPH-1 study released in May 2026) shows even better results
it also encompasses the enhancement of lean muscle mass, improvement in athletic performance, reduction in body fat, upregulation of antioxidant benefits, and strengthening of ligaments
Lets compare these options to help you determine which solution is right for you
KL1 was washed off before infection, indicating host-targeted adjuvant activity
This can cause a strain on your liver, kidneys, and other organs used in the removal of waste products, using them more than they need to
Safety and efficacy of an extended-release peptide YY analogue for obesity: a randomized, placebo-controlled, phase 1 trial